Background And Objective: To evaluate whether increased foveal thickness in clinically significant diabetic macular edema responds differently to modified focal/grid laser photocoagulation in the setting of focal versus diffuse parafoveal thickening as defined by optical coherence tomography (OCT) criteria.
Patients And Methods: The medical records of patients undergoing macular laser procedures for clinically significant diabetic macular edema were retrospectively reviewed. OCT, demographic, and clinical data were recorded for 62 consecutive eyes with clinically significant diabetic macular edema and foveal thickening (> 230 microns). Diffuse parafoveal thickening was defined as having all four parafoveal OCT quadrants greater than 300 microns, whereas focal thickening was defined as having fewer than four quadrants greater than 300 microns.
Results: Mean foveal thickness decreased from 331 to 311 microns with relatively stable visual acuity (20/54 vs 20/51) after a single laser treatment session. The diffuse parafoveal edema subgroup (24 eyes) had a mean foveal thickness change from 383 to 366 microns (P = .47) and mildly decreased visual acuity (20/62 vs 20/69). The focal parafoveal edema subgroup (38 eyes) experienced statistically significant foveal thinning from 299 to 276 microns (P = .018) and mildly improved visual acuity (20/48 to 20/43).
Conclusion: Increased foveal thickening associated with clinically significant diabetic macular edema responds more favorably to modified focal/grid laser photocoagulation in the setting of focal parafoveal edema by OCT criteria. Statistically significant foveal thinning occurred following treatment in the focal group (P = .018) but not the diffuse group (P = .47). Furthermore, eyes with focal parafoveal edema experienced a more beneficial visual acuity response than those with diffuse edema (P = .049).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3928/15428877-20090901-06 | DOI Listing |
GMS Ophthalmol Cases
December 2024
Department of Ophthalmology, Disha Eye Hospital, Siliguri, India.
Background: Pseudophakic cystoid macular edema (CME) following primary anterior-chamber intraocular lens (ACIOL) implantations is commonly seen. Intravitreal triamcinolone acetonide (IVTA) injections have shown significant improvement in visual acuity and retinal thickness in refractory pseudophakic CME. Pseudohypopyon following IVTA injection is a known entity.
View Article and Find Full Text PDFBMJ Open
December 2024
Westmead Institute for Medical Research, Westmead, New South Wales, Australia
Introduction: Diabetic macular oedema (DMO), a serious ocular complication of diabetic retinopathy (DR), is a leading cause of vision impairment worldwide. If left untreated or inadequately treated, DMO can lead to irreversible vision loss and blindness. Intravitreal injections using antivascular endothelial growth factor (anti-VEGF) and laser are the current standard of treatment for DMO.
View Article and Find Full Text PDFInt J Retina Vitreous
January 2025
Army Hospital Research & Referral, Delhi Cantt, New Delhi, Delhi, 110010, India.
Background: Management of Diabetic Macular edema (DME) requires repeated injections. Therefore newer Anti-VEGFs like Brolucizumab with longer durability have been introduced. We compared two different dosages of Brolucizumab, 6.
View Article and Find Full Text PDFActa Dermatovenerol Croat
November 2024
Prof. Marija Jelušić, MD, PhD, Department of Paediatrics, University of Zagreb, School of Medicine, Division of Clinical Immunology, Rheumatology and Allergology, Centre of Reference for Paediatric and Adolescent Rheumatology of Ministry of Health of the Republic Croatia, University Hospital Centre Zagreb, Kispaticeva 12, 10 000 Zagreb, Croatia;
Juvenile dermatomyositis with emphasized vasculopathy is rare, but the most severe form of the disease, with a poor prognosis with relapsing and chronic course or, in some cases, lethal outcome. We present a case of a 19-year-old Caucasian female, who developed severe acute juvenile dermatomyositis with emphasized multisystem vasculopathy, including retinal vasculopathy and maculopathy (cotton-wool spots, retinal hemorrhages, macular edema) at the age of 8. Due to no response to standard treatment protocols and rapid worsening of clinical symptoms and laboratory findings, a TNF inhibitor (infliximab) was introduced after the third week of treatment resulting in complete normalisation of muscle enzyme levels and complete resolution of eye changes within the next 2 weeks with a gradual general recovery.
View Article and Find Full Text PDFPurpose: The purpose of this study is to evaluate the impact of foveal bulge presence on visual acuity (VA) in patients with diabetic macular edema (DME) and retinal vein occlusion (RVO).
Methods: Spectral-domain optical coherence tomography (SD-OCT) scans were conducted on 22 DME patients and 20 RVO patients. Ordinary least squares (OLS) regression was employed to analyze the association between VA and the presence of the foveal bulge, as well as factors such as sex, age, central foveal thickness, various line scans of the fovea, and the external limiting membrane (ELM).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!